Aspirin resistance: more than just a laboratory curiosity
Top Cited Papers
- 17 March 2004
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 43 (6), 1127-1129
- https://doi.org/10.1016/j.jacc.2004.01.022
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatmentJournal of the American College of Cardiology, 2004
- Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary SyndromesCirculation, 2003
- Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular DiseaseCirculation, 2003
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJournal of the American College of Cardiology, 2003
- Scientific and therapeutic advances in antiplatelet therapyNature Reviews Drug Discovery, 2003
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Underuse of aspirin in a referral population with documented coronary artery diseaseThe American Journal of Cardiology, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Profile and prevalence of aspirin resistance in patients with cardiovascular diseaseThe American Journal of Cardiology, 2001
- ANTIPLATELET AND ANTICOAGULANT THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC HEART DISEASEMedical Clinics of North America, 2000